[ad_1]
Al-Marsad Journal: The Food and Drug Authority issued a decision suspending the registration and withdrawal of the preparation (LORA S Tablet) registered under the authorization number (8-968-15) and the preparation (LORINASE TABLETS ) registered under the authorization number
(250-212-09).
The Food and Drug Administration has declared that the product (LORA S Tablet) is marketed by Dammam Pharma and that the product (LORINASE Tablet) is marketed by the Saudi Company for Medicinal Industries and Medical Supplies (SPIMACO), and the registration has been withdrawn and suspended The two products are not biocompatible with the reference preparation.
The authority approached health authorities to withdraw the preparations as soon as they were available, and also approached companies marketing the preparations to withdraw them from all beneficiaries, calling on their users to consult the doctor. specialist to exchange the alternative.
Source link
